Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Self- vs Nurse-Administered Intradermal Influenza Vaccine
NCT01224613Phase 4Completed
- Sponsor
- Dalhousie University
- Start
- Nov 2010
- Primary completion
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of IDflu in influenza, sponsored by Dalhousie University. Started Nov 2010; status: completed.
02
Drugs
IDflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01224613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224613.